Delay in Breast Cancer Treatments During the First COVID-19 Lockdown. A Multicentric Analysis of 432 Patients

Extraordinary restrictions aimed to limit Sars-CoV-2 spreading; they imposed a total reorganization of the health-system. Oncological treatments experienced a significant slowdown. The aim of our multicentric retrospective study was to evaluate screening suspension and surgical treatment delay durin...

Full description

Saved in:
Bibliographic Details
Published in:Anticancer research 2020-12, Vol.40 (12), p.7119-7125
Main Authors: Vanni, Gianluca, Tazzioli, Giovanni, Pellicciaro, Marco, Materazzo, Marco, Paolo, Orsaria, Cattadori, Francesca, Combi, Francesca, Papi, Simona, Pistolese, Chiara Adriana, Cotesta, Maria, Santori, Francesca, Caspi, Jonathan, Chiaravalloti, Agostino, Muscoli, Saverio, Lombardo, Vittorio, Grasso, Antonella, Caggiati, Lorenza, Raselli, Roberta, Palli, Dante, Altomare, Vittorio, D'Angelillo, Rolando Maria, Palombi, Leonardo, Buonomo, Oreste Claudio
Format: Article
Language:English
Subjects:
Adult
Aged
Aged, 80 and over
Axilla - pathology
Axilla - surgery
Breast cancer
Breast Neoplasms - complications
Breast Neoplasms - epidemiology
Breast Neoplasms - surgery
Breast Neoplasms - virology
Cancer therapies
Coronaviruses
COVID-19
COVID-19 - complications
COVID-19 - epidemiology
COVID-19 - virology
Disease transmission
Evaluation
Female
Humans
Lymph Node Excision
Lymph Nodes
Lymphatic Metastasis
Lymphatic system
Mastectomy
Middle Aged
Multivariate analysis
Pandemics
Patients
Retrospective Studies
SARS-CoV-2 - pathogenicity
Sentinel Lymph Node Biopsy
Severe acute respiratory syndrome coronavirus 2
Shelter in place
Statistical analysis
Surgery
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Extraordinary restrictions aimed to limit Sars-CoV-2 spreading; they imposed a total reorganization of the health-system. Oncological treatments experienced a significant slowdown. The aim of our multicentric retrospective study was to evaluate screening suspension and surgical treatment delay during COVID-19 and the impact on breast cancer presentation. All patients who underwent breast surgery from March 11, 2020 to May 30, 2020 were evaluated and considered as the Lockdown group. These patients were compared with similar patients of the previous year, the Pre-Lockdown group. A total of 432 patients were evaluated; n=223 and n=209 in the Lockdown and Pre-lockdown-groups, respectively. At univariate analysis, waiting times, lymph-nodes involvement and cancer grading, showed a statistically significant difference (p
ISSN:0250-7005
1791-7530
DOI:10.21873/anticanres.14741